Utilizing Dynamic Risk Stratification in Patients With Tall Cell Variant Papillary Thyroid Cancer
The Laryngoscope · 2023
DOI: 10.1002/lary.30725 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, 2023. Verfasst von David Zimmer und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Head and Neck Institute, Cleveland Clinic, Cleveland, Ohio, U.S.A. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Carcinoma, Papillary. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objectives
Tall cell variant (TCV) papillary thyroid cancer (PTC) is a subtype of PTC associated with aggressive tumor behavior, advanced stage, and higher rates of recurrence and mortality. The present study aimed to test an established dynamic risk stratification tool in the TCV population, with the goal of better predicting the postoperative course of these patients. Study Design Retrospective chart review.
Methods
A total of 94 patients with TCV who underwent total thyroidectomy with radioactive iodine ablation were retrospectively reviewed from 1998 through 2020. Biochemical, structural, and overall response to treatment was determined for each patient, based on postoperative thyroglobulin levels and imaging findings. Primary outcomes were locoregional and distant recurrence, presence of disease at final follow‐up, need for additional intervention, and disease‐specific mortality.
Results
Patients with TCV who were stratified as having an excellent overall response to treatment had lower rates of locoregional recurrence than indeterminate, biochemical incomplete, and structural incomplete responses (2.0%, 33.3%, 55.0%, and 85.7% at 5 years respectively, p < 0.001). The same was true for distant recurrence as well (2.0%, 9.0%, 35.1%, and 42.9%, p < 0.001). An excellent response was also associated with lower rates of presence of disease at final follow‐up, need for additional intervention, and disease‐specific mortality.
Conclusions
Although TCV is an aggressive subtype associated with worse clinical outcomes than classical PTC, patients with an excellent overall response to treatment have significantly improved outcomes when compared to indeterminate, biochemical incomplete, and structural incomplete responses. Level of Evidence 3 Laryngoscope , 133:2430–2438, 2023
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Head and Neck Institute, Cleveland Clinic, Cleveland, Ohio, U.S.A.
- Department of General Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, Ohio, U.S.A.
- Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, U.S.A.
- Department of Endocrinology, Diabetes, and Metabolism, Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, Ohio, U.S.A.
- Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, U.S.A.
- Department of Endocrine Surgery, Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, Ohio, U.S.A.
ORCID-Profile: David Zimmer
Zitieren
APA
Zimmer, D., Plitt, G., Prendes, B., Ku, J., Silver, N., Lamarre, E., Yilmaz, E., Geiger, J., Nasr, C., El Hage, L., Skugor, M., Cambpell, S., Koyfman, S., Miller, J., Woody, N., Heiden, K., Joshi, N., Elsheikh, T., Li, H., & Scharpf, J. (2023). Utilizing Dynamic Risk Stratification in Patients With Tall Cell Variant Papillary Thyroid Cancer. The Laryngoscope. https://doi.org/10.1002/lary.30725
Vancouver
Zimmer D, Plitt G, Prendes B, Ku J, Silver N, Lamarre E, et al. Utilizing Dynamic Risk Stratification in Patients With Tall Cell Variant Papillary Thyroid Cancer. The Laryngoscope. 2023. doi:10.1002/lary.30725
BibTeX
@article{Zimmer2023,
author = {Zimmer, David and Plitt, Gilman and Prendes, Brandon and Ku, Jamie and Silver, Natalie and Lamarre, Eric and Yilmaz, Emrullah and Geiger, Jessica and Nasr, Christian and El Hage, Lea and Skugor, Mario and Cambpell, Shauna and Koyfman, Shlomo and Miller, Jacob and Woody, Neil and Heiden, Katherine and Joshi, Nikhil and Elsheikh, Tarik and Li, Hong and Scharpf, Joseph},
title = {Utilizing Dynamic Risk Stratification in Patients With Tall Cell Variant Papillary Thyroid Cancer},
journal = {The Laryngoscope},
year = {2023},
doi = {10.1002/lary.30725}
}
EUVIMED